Hepatitis B testing should be done before hepatitis C treatment due to risk of HBV reactivation
100% cure rate for people with HCV genotype 1 treated with AL-335, odalasvir and simeprevir for 6 or 8 weeks
Risk of reinfection is a concern after successful hepatitis C treatment
EASL issues new hepatitis C treatment recommendations for all genotypes
HCV treatment is effective and may work as prevention for people who inject drugs
Effective antiviral treatment reduces fatigue in people with chronic hepatitis C
INHSU 2016 opens with focus on hepatitis C prevention and treatment for people who inject drugs
AbbVie 3D and 2D hepatitis C combos work well for people with HIV and HCV co-infection
Sofosbuvir/velpatasvir shows high cure rate in HIV/HCV co-infection study
